Please note: This event has reached the capacity. Click Register Here to be added to the waitlist.

What to Expect

On August 13, Johnson & Johnson will host members of the Boston biotech ecosystem at LabCentral for ‘Leading the Way with J&J: Spotlight on Oncology’, an evening spotlighting groundbreaking advancements in the field of oncology and their ongoing collaborations with some of the brightest minds in the industry. 

We’ll set the stage with an overview of Boston’s rich innovation ecosystem and the impact of collaboration on accelerating innovation, particularly in the realm of cancer care. We’ll explore the current landscape, and look ahead to what may be the next breakthrough innovation that will address the greatest unmet healthcare needs as part of our mission to ‘get in front of cancer’. 

Our first presentation and panels will welcome J&J oncology leaders to share their perspectives in a panel discussion on trends they foresee shaping the field and key areas of interest for Johnson & Johnson Innovative Medicine.  

After the program ends, immerse yourself in our networking session, a buzzing hive of like-minded visionaries and industry trailblazers!

Be sure to register today to secure your spot as we expect this event to fill up fast!

Featured Speakers

Opening Remarks

Michal Preminger
Head, J&J Innovation
East North America

Carla Reimold
VP, Industry Strategy and Investments
Massachusetts Life Sciences Center

Robert Radinsky
VP, Oncology Scientific Innovation
J&J Innovative Medicine

Jeff Infante
VP, Early Development and External Innovation
J&J Innovative Medicine

Panel ‘Oncology External Innovation Strategy’ 

Jeff Infante
VP, Early Development and External Innovation
J&J Innovative Medicine

Charles Drake
VP, Prostate and Immunotherapy DAS
J&J Innovative Medicine

Jordan Schecter
VP, Multiple Myeloma DAS
J&J Innovative Medicine

Johan Verbeeck
VP, Business Development Oncology
J&J Innovative Medicine

Allison Fritts
VP, Business Development Oncology (Solid Tumor)
J&J Innovation

Robert Radinsky
VP, Oncology Scientific Innovation
J&J Innovative Medicine

Moderator

Panel ‘Multiple Myeloma, Immune Oncology, Cellular Therapy at J&J Innovative Medicine’

Jordan Schecter
VP, Multiple Myeloma DAS
J&J Innovative Medicine

Charles Drake
VP, Prostate and Immunotherapy DAS
J&J Innovative Medicine

Molly Perkins
VP, Cell Therapy, R&D
J&J Innovative Medicine

Jeff Infante
VP, Early Development and External Innovation
J&J Innovative Medicine

Leo MacDonald
VP, Business Development Oncology (Heme and IO)
J&J Innovation

Erica Bozeman
Associate Director, Oncology External Innovation
J&J Innovative Medicine

Moderator

Featured Attendees

Jian Yin
Executive Medical Director, Oncology, Medical Education
J&J Innovative Medicine

Allison Montalvo
Senior Director, CAR-T Platform Leader
J&J Innovative Medicine

Hong Xin
Senior Director, External Innovation
Search & Evaluation
J&J Innovative Medicine

Dozie Amuzie
Head, JLABS Canada
J&J Innovation

Tingting Zhang-Kharas
Head, JLABS Northeast
J&J Innovation

Please note: This event has reached the capacity. Click Register Here to be added to the waitlist.